Login

Symposium on Cannabinoids and Pain

Poster Presentations and Reception
17:15-19:00

Room: St. Jacques (one floor below the main presentation room)

Poster Presenters: 

Poster Presenters are asked to register at the main registration counter.  Poster display boards will be set up in the 'St. Jacques' room, one floor above the main presentation room.  Presenter names and titles will be indicated on the poster display boards.   Velcro dots and pins will be available in the room.
If you have any questions or concerns, please contact:
Daniel Ziemianski
1-514-934-1934 ext. 44363
 
Francois Chouinard
Samuel Poirier
Julie S Lefebvre
Nicolas Flamand
 
Leukotrienes Derived From The Hydrolysis Of 2-Arachidonoyl-Glycerol Activate Human Neutrophils
Shaohua Lu
Soma Ganesan
Boris Feldman
Mario McKenna
 
A Double-Blind Placebo Control Pilot Study On The Use Of Nabilone For The Management Of Acute Marijuana Use
Ryan J. McLaughlin
Matthew N. Hill
Silvain Dang
Bruce S. McEwen
Cecilia J. Hillard
B.B. Gorzalka
 
Cannabinoid Cb1 Receptor Binding In The Ventromedial Prefrontal Cortex Is Significantly Upregulated Following Exposure To Chronic Unpredictable Stress
I.A. Khasabova
D.N. Vetter
C. Harding-Rose
V.S. Seybold
D.A. Simone
 
Drugs That Facilitate Anandamide Signaling Decrease Hyperalgesia In A Cisplatin Model Of Neuropathy
Cory Toth
Nicole Jedrzejewski
Connie Ellis
William H. Frey II
 
Cannabinoid-Mediated Modulation Of Neuropathic Pain And Microglial Accumulation In A Model Of Murine Type I Diabetic Peripheral Neuropathic Pain
Dana A. Turcotte
Micheal P. Namaka
Andrew J. Gomori
Farid Esfahani
 
A Randomized, Double-Blinded, Placebo-Controlled Study Evaluating The Efficacy And Safety Of Nabilone As An Adjunctive To Gabapentin In Managing Multiple Sclerosis-Induced Neuropathic Pain: An Interim Analysis
Mark A. Ware
Roman Jovey
Joel Singer
Mary Lynch
 
Cannabinoid Abuse Potential (CAPO) Baseline Data From A National Perspective Study
Sharleen Yuan
Brian Burrell
 
Endocannabinoid-Dependent LTD Requires TRPV Activation In Nociceptive Signaling
 

Submission Details

Submit your abstract application by email!

Please save this file as a Word document using your family name as the title. Please use the email subject heading “Cannabinoids and Pain Symposium abstract” and email the file as an attachment to: info@ccic.net

General Information

Poster abstract submissions will be reviewed and rated by members of the Scientific Committee of the CCIC who have expertise in cannabinoid and pain research. Each submission will be reviewed for its scientific or clinical importance, ethical practice, study design and relevance to the symposium theme.

The primary author will be asked to sign an Abstract Submission Agreement which confirms that the primary author agrees to grant the CCIC permission to publish the abstract in printed symposium material and on the CCIC website. The primary author retains the abstract’s copyright, and anyone wishing to use the abstract after the Cannabinoids and Pain Symposium will be instructed to contact the primary author. The CCIC reserves the right to withdraw the abstract.

There is no abstract submission fee for the Poster Session, however all poster abstract applicants must be registered for the symposium. At least one author must attend the symposium and accompany their poster during the poster session.

To download the Abstract Proposal Click Here.